Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Positive phase I results reported for TCAR product for MS

Feb. 24, 1998

CPMP recommends European approval of Exelon

Feb. 24, 1998

Muscarinic cholinergic agents from American Home

Feb. 24, 1998

Neurocrine Biosciences reveals new technology

Feb. 24, 1998

Evaluation of the analgesic potential of 1,2,6-IP3

Feb. 24, 1998

Excellent anxiolytic/side effect profile described for LY-354740

Feb. 23, 1998

Reduction in brain damage with YM-872 in cat model of focal cerebral ischemia

Feb. 23, 1998

Ganaxolone demonstrates efficacy in phase II migraine trial

Feb. 23, 1998

Novel NK1 antagonists described by Merck & Co.

Feb. 23, 1998

Antidepressant properties of flibanserin may involve dopamine D2/D3 receptors

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...